Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 658B (ZNF658B) is classified as a pseudogene in humans, located on chromosome 9[1][5][9]. It is predicted, based on homology and domain structure, to possess a zinc finger domain, which typically mediates DNA binding and transcriptional regulation[1][2][9]. However, there is no direct experimental evidence confirming the expression of a functional protein, nor established biological functions, disease associations, or therapeutic targeting. As such, ZNF658B is currently not recognized as an active therapeutic target or biologically characterized molecule[1][2][9]. Key issues: - ZNF658B is referred to as a pseudogene in all curated databases, meaning it likely does not encode a functional protein[1][2][5][9]. - There is no canonical protein product; its predicted roles are inferred solely from domain homology and bioinformatic analysis, not experimental data[1][2][9]. - No evidence of drug interaction, biomarker relevance, or safety concerns is available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 658B (pseudogene) (ZNF658B).